Nephros Statistics

Total Valuation

Nephros has a market cap or net worth of $35.34 million. The enterprise value is $30.47 million.

Market Cap	35.34M
Enterprise Value	30.47M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Nephros has 10.64 million shares outstanding. The number of shares has increased by 3.45% in one year.

Current Share Class	10.64M
Shares Outstanding	10.64M
Shares Change (YoY)	+3.45%
Shares Change (QoQ)	+1.49%
Owned by Insiders (%)	5.49%
Owned by Institutions (%)	44.73%
Float	9.45M

Valuation Ratios

The trailing PE ratio is 30.18 and the forward PE ratio is 55.33.

PE Ratio	30.18
Forward PE	55.33
PS Ratio	1.85
Forward PS	1.66
PB Ratio	3.37
P/TBV Ratio	3.88
P/FCF Ratio	21.16
P/OCF Ratio	21.16
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.71, with an EV/FCF ratio of 18.52.

EV / Earnings	25.52
EV / Sales	1.62
EV / EBITDA	23.71
EV / EBIT	26.59
EV / FCF	18.52

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.10.

Current Ratio	4.06
Quick Ratio	2.82
Debt / Equity	0.10
Debt / EBITDA	0.61
Debt / FCF	0.65
Interest Coverage	1,146.00

Financial Efficiency

Return on equity (ROE) is 12.71% and return on invested capital (ROIC) is 19.14%.

Return on Equity (ROE)	12.71%
Return on Assets (ROA)	5.76%
Return on Invested Capital (ROIC)	19.14%
Return on Capital Employed (ROCE)	10.54%
Weighted Average Cost of Capital (WACC)	12.46%
Revenue Per Employee	$521,917
Profits Per Employee	$33,167
Employee Count	36
Asset Turnover	1.51
Inventory Turnover	2.45

Taxes

In the past 12 months, Nephros has paid $12,000 in taxes.

Income Tax	12,000
Effective Tax Rate	1.00%

Stock Price Statistics

The stock price has increased by +65.17% in the last 52 weeks. The beta is 1.56, so Nephros's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	+65.17%
50-Day Moving Average	3.32
200-Day Moving Average	4.23
Relative Strength Index (RSI)	58.70
Average Volume (20 Days)	22,498

Short Selling Information

The latest short interest is 46,667, so 0.44% of the outstanding shares have been sold short.

Short Interest	46,667
Short Previous Month	5,414
Short % of Shares Out	0.44%
Short % of Float	0.49%
Short Ratio (days to cover)	0.96

Income Statement

In the last 12 months, Nephros had revenue of $18.79 million and earned $1.19 million in profits. Earnings per share was $0.11.

Revenue	18.79M
Gross Profit	11.63M
Operating Income	1.15M
Pretax Income	1.21M
Net Income	1.19M
EBITDA	1.29M
EBIT	1.15M
Earnings Per Share (EPS)	$0.11

Full Income Statement

Balance Sheet

The company has $5.40 million in cash and $1.06 million in debt, giving a net cash position of $4.34 million or $0.41 per share.

Cash & Cash Equivalents	5.40M
Total Debt	1.06M
Net Cash	4.34M
Net Cash Per Share	$0.41
Equity (Book Value)	10.20M
Book Value Per Share	0.96
Working Capital	8.46M

Full Balance Sheet

Cash Flow

Operating Cash Flow	1.65M
Capital Expenditures	n/a
Depreciation & Amortization	139,000
Net Borrowing	-5,000
Free Cash Flow	1.65M
FCF Per Share	$0.15

Full Cash Flow Statement

Margins

Gross margin is 61.87%, with operating and profit margins of 6.10% and 6.35%.

Gross Margin	61.87%
Operating Margin	6.10%
Pretax Margin	6.42%
Profit Margin	6.35%
EBITDA Margin	6.84%
EBIT Margin	6.10%
FCF Margin	8.76%

Dividends & Yields

Nephros does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.45%
Shareholder Yield	-3.45%
Earnings Yield	3.43%
FCF Yield	4.73%

Analyst Forecast

The average price target for Nephros is $6.00, which is 80.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	80.72%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 10, 2019. It was a reverse split with a ratio of 1:9.

Last Split Date	Jul 10, 2019
Split Type	Reverse
Split Ratio	1:9

Scores

Nephros has an Altman Z-Score of -6.09 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.09
Piotroski F-Score	6